Associate Chair of Operations
Phone: (206) 685-6831
Office: Foege N410D
UW Bioengineering assistant professor Dr. Kim Woodrow

Kim Woodrow

My laboratory is focused on the application of engineered biomaterials in mucosal infections and mucosal immunity to develop solutions which address significant challenges in biomedicine and global health.
Drug delivery
Mucosal biology
Multidrug combinations
The Woodrow Laboratory is focused on the applications of engineered biomaterials in mucosal infections and mucosal immunity. Our long-term goals are to design and build multifunctional materials that will: (1) lead to novel preventative strategies for mucosal infections, (2) program protective immune responses at mucosal sites of pathogen entry, and (3) assist studies of mucosal infections and mucosal immunity in health and disease. These scientific goals are addressed from the perspective of fundamental science, technology development, and translational research. We are a highly interdisciplinary group that implements knowledge and tools from all areas of science and engineering. We strive to innovate solutions that will have the greatest impact in biomedicine and global health technologies.
PhD, Chemical Engineering, Stanford University, 2005
MS, Chemical Engineering, Stanford University, 2002
BA, Wells College, 1998
Postdoc, Biomedical Engineering, Yale University, 2006-2009
NIH Director’s New Innovator Award, 2012
Creative and Novel Ideas in HIV Research, 2010
L’Oreal USA Fellowship for Women in Science, 2008
NIH Vascular Research Postdoctoral Training Fellowship, 2008
NIH Genomics Postdoctoral Training Fellowship, 2006
Centennial Teaching Assistant Award, Stanford University, 2003
National Science Foundation Graduate Research Fellowship, 1999
Phi Beta Kappa, 1998
Nancy A. Reed Chemistry Prize, 1998
Henry Wells Scholar, 1994
BIOEN 401: Bioengineering Capstone Principles
BIOEN 498: Immunoengineering
Chaowanachan, T., Krogstand, E., Ball, C., Woodrow, K.A. “Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis. PloS ONE, 2013, 8(4), p. e61416.

Ball, C., Krogstad, E., Chaowanachan, T., and Woodrow, K.A. “Drug-eluting fibers for HIV-1 inhibition and contraception.” PloS ONE, 2012, 7(11), p. e49792.

Woodrow, K.A., Bennett, K., and Lo, D. “Mucosal Vaccine Design and Delivery,” Annu Rev Biomed Eng, 2012, 14, pp. 17-36.

Woodrow, K.A., Cu, Y., Booth, C.J., Saucier-Sawyer, J.K., Wood, M.J., and Saltzman, W.M. “Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA.” Nature Materials, 2009, 8(6): p. 526-533.

Woodrow, K.A., Wood, M.J., Saucier-Sawyer, J.K., and Saltzman, W.M. “Biodegradable meshes printed with extracellular matrix proteins support micropatterned hepatocyte cultures.” Tissue Engineering Part A, 2009, 15(5): p. 1169-79.

Woodrow, K.A. and Swartz J.R. “A Sequential expression system for high-throughput functional genomic analysis.” Proteomics, 2007, 7: 3870-3879.

Woodrow, K.A., Airen, I.O., and Swartz, J.R. “Rapid expression of functional genomic libraries.” J Proteome Res, 2006, 5: 3288-3300.

Michel-Reydellet, N., Woodrow, K.A., and Swartz, J.R. “Increasing PCR fragments stability and protein yields in a cell-free system with genetically modified Escherichia coli extract.” J Mol Microbiol Biotechnol, 2005, 9: 26-34.

Belcheva, N., Woodrow, K., Mahoney, M.J., and Saltzman W.M. “Synthesis and biological activity of polyethylene glycol-mouse nerve growth factor conjugate.” Bioconjug Chem, 1999, 10: 932-937.

Luo, D., Belcheva, N., Woodrow, K., and Saltzman, W.M. “Controlled DNA delivery systems.” Pharm Res, 1999, 16: 1300-1308.

In the News